Moderna begins COVID-19 vaccine trial in kids under age of 12


Moderna Inc. has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday.

View original article here Source

Related Posts